Source: Annual Congress 2005 - Systemic effects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. H. Torres, M. C. MontesdeOca, J. B. De Sanctis, A. Mata, N. Hernández, C. Tálamo (Caracas, Venezuela). Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD). Eur Respir J 2005; 26: Suppl. 49, 4201

Member's Comments

No comment yet.

Related content which might interest you: Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Desmosin as a marker for tissue injury in COPD Source: Annual Congress 2007 - α1-Antitrypsin deficiency: molecular and clinical news Year: 2007 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002 Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 The effect of COPD on muscle structure and function Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles Year: 2006 Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Cardiac muscle mass and function are associated with altered body composition in patients with COPD Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Impact of oxygen supplementation on inflammatory response and muscle lesion during high intensity exercise on chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - Muscles, training and rehabilitation Year: 2006 Body composition and plasma levels of inflammatory biomarkers in COPD Source: Eur Respir J 2010; 36: 1027-1033 Year: 2010 Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Source: Eur Respir J 2003; 22: 81S-86S Year: 2003 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Systemic inflammation in chronic respiratory disease Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=46 Year: 2003 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1 Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016